MediciNova, Inc. (MNOV) At $10.39 Forms Top; USANA Health Sciences, Inc. (USNA) Covered By 1 Bullish Analysts Last Week

May 18, 2018 - By Peter Kolinski

USANA Health Sciences, Inc. (NYSE:USNA) Logo

Among 3 analysts covering USANA Health Science (NYSE:USNA), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. USANA Health Science had 11 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was downgraded by Sidoti to “Neutral” on Wednesday, January 24. The firm has “Buy” rating given on Wednesday, October 25 by Pivotal Research. DA Davidson upgraded USANA Health Sciences, Inc. (NYSE:USNA) on Wednesday, September 16 to “Buy” rating. The rating was downgraded by Pivotal Research to “Hold” on Monday, April 23. Pivotal Research maintained USANA Health Sciences, Inc. (NYSE:USNA) on Wednesday, February 8 with “Buy” rating. The firm has “Neutral” rating by DA Davidson given on Thursday, August 6. The rating was downgraded by Pivotal Research to “Hold” on Monday, May 1. The stock of USANA Health Sciences, Inc. (NYSE:USNA) has “Hold” rating given on Wednesday, August 5 by Pivotal Research. The stock of USANA Health Sciences, Inc. (NYSE:USNA) has “Buy” rating given on Friday, October 16 by Sidoti. See USANA Health Sciences, Inc. (NYSE:USNA) latest ratings:

23/04/2018 Broker: Pivotal Research Old Rating: Buy New Rating: Hold Downgrade
24/01/2018 Broker: Sidoti Old Rating: Buy New Rating: Neutral Downgrade

MediciNova, Inc. (MNOV) formed multiple top with $11.22 target or 8.00% above today’s $10.39 share price. MediciNova, Inc. (MNOV) has $427.33 million valuation. The stock decreased 1.14% or $0.12 during the last trading session, reaching $10.39. About 104,552 shares traded. MediciNova, Inc. (NASDAQ:MNOV) has risen 98.80% since May 18, 2017 and is uptrending. It has outperformed by 87.25% the S&P500.

Among 2 analysts covering Medicinova (NASDAQ:MNOV), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Medicinova has $2200 highest and $22 lowest target. $22’s average target is 111.74% above currents $10.39 stock price. Medicinova had 2 analyst reports since March 28, 2018 according to SRatingsIntel. As per Wednesday, March 28, the company rating was initiated by FBR Capital.

Investors sentiment decreased to 1.79 in Q4 2017. Its down 0.88, from 2.67 in 2017Q3. It worsened, as 7 investors sold MediciNova, Inc. shares while 7 reduced holdings. 6 funds opened positions while 19 raised stakes. 7.63 million shares or 3.16% less from 7.88 million shares in 2017Q3 were reported. California Pub Employees Retirement reported 0% stake. Morgan Stanley invested in 86,588 shares. Vanguard Gp has 1.26M shares for 0% of their portfolio. Rhumbline Advisers reported 30,020 shares. 137 are held by Royal Bancorp Of Canada. Blackrock Inc reported 1.71M shares. Tiaa Cref Investment Management accumulated 92,757 shares or 0% of the stock. New York State Common Retirement Fund has invested 0% in MediciNova, Inc. (NASDAQ:MNOV). Grp Incorporated Inc has 23,041 shares for 0% of their portfolio. Voya Invest Mngmt Ltd accumulated 19,341 shares. Schwab Charles Inv Mngmt invested 0% in MediciNova, Inc. (NASDAQ:MNOV). Alps Advsr Incorporated owns 40,004 shares. Barclays Public Limited Company holds 0% or 5,561 shares in its portfolio. State Board Of Administration Of Florida Retirement Sys reported 10,011 shares. Legal And General Grp Pcl holds 7,603 shares or 0% of its portfolio.

Since February 2, 2018, it had 0 buys, and 20 insider sales for $84.11 million activity. Gull Global Ltd had sold 228,000 shares worth $18.49 million. WENTZ MYRON W sold $18.49 million worth of USANA Health Sciences, Inc. (NYSE:USNA) on Thursday, March 8. On Tuesday, May 1 the insider IIEKKING G DOUG sold $53,824. The insider Jones Paul A. sold $866,376. Another trade for 3,075 shares valued at $236,775 was made by Noot Walter on Thursday, February 15.

USANA Health Sciences, Inc. develops, makes, and sells science nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company has market cap of $2.84 billion. The firm offers USANA Nutritionals Essentials product line, which includes vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It has a 46.46 P/E ratio. It also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups.

More important recent USANA Health Sciences, Inc. (NYSE:USNA) news were published by: Seekingalpha.com which released: “USANA’s (USNA) CEO Kevin Guest on Q1 2018 Results – Earnings Call Transcript” on April 25, 2018, also Seekingalpha.com published article titled: “Featured Stocks In May’s Most Attractive/Most Dangerous Model Portfolios”, Benzinga.com published: “Earnings Scheduled For April 24, 2018” on April 24, 2018. More interesting news about USANA Health Sciences, Inc. (NYSE:USNA) was released by: Businesswire.com and their article: “USANA Health Sciences Reports Record First Quarter 2018 Net Sales and Increases 2018 Outlook” with publication date: April 24, 2018.

The stock increased 2.93% or $3.35 during the last trading session, reaching $117.55. About 150,420 shares traded or 1.73% up from the average. USANA Health Sciences, Inc. (NYSE:USNA) has risen 44.07% since May 18, 2017 and is uptrending. It has outperformed by 32.52% the S&P500.

Investors sentiment decreased to 1.19 in 2017 Q4. Its down 0.06, from 1.25 in 2017Q3. It is negative, as 13 investors sold USANA Health Sciences, Inc. shares while 45 reduced holdings. 25 funds opened positions while 44 raised stakes. 10.77 million shares or 5.27% more from 10.23 million shares in 2017Q3 were reported. Globeflex Ltd Partnership stated it has 22,229 shares. Creative Planning holds 2,960 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Management owns 45,700 shares. 142,912 are held by Deutsche Bancorporation Ag. Us National Bank De has invested 0% in USANA Health Sciences, Inc. (NYSE:USNA). Renaissance Lc invested in 0.16% or 1.93M shares. New York State Teachers Retirement Sys invested 0% in USANA Health Sciences, Inc. (NYSE:USNA). Moreover, Pnc Fincl Services Gp Inc has 0% invested in USANA Health Sciences, Inc. (NYSE:USNA). New York-based Jpmorgan Chase Co has invested 0% in USANA Health Sciences, Inc. (NYSE:USNA). 17,510 were accumulated by Automobile Association. Alps Advisors Incorporated holds 0% or 8,141 shares. Symons Cap Management, a Pennsylvania-based fund reported 5,181 shares. Fort Limited Partnership stated it has 0.91% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA). Bessemer Grp Inc reported 12,900 shares or 0% of all its holdings. 234,014 were reported by Old Mutual Glob (Uk) Limited.

USANA Health Sciences, Inc. (NYSE:USNA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>